<DOC>
	<DOCNO>NCT02209688</DOCNO>
	<brief_summary>The objective study obtain safety tolerability data first pharmacokinetic pharmacodynamic data escalate dos ESR 1150 CL .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Pharmacodynamics ESR 1150 CL Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male female Caucasian subject determine result screen Written informed consent accordance Good Clinical Practice local legislation give Age ≥ 18 ≤ 50 year Broca ≥ 20 % ≤ + 20 % first part study : extensive metabolizers CYP2D6 and/or `` spartein '' type ; second part study : poor metabolizers CYP2D6 and/or `` spartein '' Any find medical examination ( include blood pressure , pulse rate electrocardiogram ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder History orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( &gt; 24 hour ) ( ≤ 1 month prior administration trial , except oral contraceptive ) Use drug might influence result trial ( ≤ 10 day prior administration trial except oral contraceptive ) Participation another trial investigational drug ( ≤ 2 month prior administration trial ) Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Inability refrain smoke trial day Alcohol abuse ( &gt; 60 g/days ) Drug abuse Blood donation &gt; 100 ml ( ≤ 4 week prior administration trial ) Excessive physical activity ( ≤ 10 day prior administration trial ) Any laboratory value outside reference range clinical relevance Females : No reliable contraception ( examples reliable contraception : oral contraceptive , 3month injection , intrauterine device , sterilisation , condom + spermicide ) pregnancy breast feeding period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>